CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

Nature Medicine 24, 20 (2018).
doi:10.1038/nm.4441

Authors: Terry J Fry, Nirali N Shah, Rimas J Orentas, Maryalice Stetler-Stevenson, Constance M Yuan, Sneha Ramakrishna, Pamela Wolters, Staci Martin, Cindy Delbrook, Bonnie Yates, Haneen Shalabi, Thomas J Fountaine, Jack F Shern, Robbie G Majzner, David F Stroncek, Marianna Sabatino, Yang Feng, Dimiter S Dimitrov, Ling Zhang, Sang Nguyen, Haiying Qin, Boro Dropulic, Daniel W Lee & Crystal L Mackall

Source: Nature Medicine - November 20, 2017 Category: General Medicine Authors: Terry J Fry Nirali N Shah Rimas J Orentas Maryalice Stetler-Stevenson Constance M Yuan Sneha Ramakrishna Pamela Wolters Staci Martin Cindy Delbrook Bonnie Yates Haneen Shalabi Thomas J Fountaine Jack F Shern Robbie G Majzner David F Stroncek Marianna Saba Tags: Article Source Type: research